Study Overview Sample Clauses

Study Overview. Study Title [Drafting note: ARENA to complete. Insert full long name in accordance with ARENA’s naming convention] i.e. [GMS Number] [Name] [GMS Number] [study] Contract Number [Drafting note: ARENA to complete – to be obtained from ARENA’s GMS] Recipient [Drafting note: Recipient to insert full legal name and ABN] Guidelines and policies Industrial Energy Transformation Studies Program –[insert Round and Stream] [Applicable Guidelines to be inserted – link to Project plan page on webpage] ARENA Variation Policy (▇▇▇▇▇://▇▇▇▇▇.▇▇▇.▇▇/▇▇▇▇▇▇/▇▇▇▇/▇▇/▇▇▇▇▇-▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇.▇▇▇) ARENA Report Writing Guidelines (▇▇▇▇▇://▇▇▇▇▇.▇▇▇.▇▇/▇▇▇▇▇▇/▇▇▇▇/▇▇/▇▇▇▇▇-▇▇▇▇▇▇-▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇▇▇.▇▇▇)

Study Overview. The purpose of this study is to examine undergraduates’ experiences that influence continuing or discontinuing a pursuit of the pre-medical educational track.

Study Overview. ‌ This is a phase 2, multi-center, randomized, double-blind, placebo-controlled trial in adults with CF chronically infected with P. aeruginosa. The study will evaluate the safety and clinical efficacy of a five-day infusion of IV gallium nitrate. Approximately one hundred twenty eligible subjects will be randomized in equal allocation to receive either a single 5-day infusion of IV gallium or volume-matched placebo. Subjects will be randomized using an adaptive randomization scheme to prevent imbalances in treatment allocation within baseline FEV1 strata. Five study visits will occur at Screening/Baseline (Day 1; Visit 1), Day 6 (Visit 2), Day 14 (Visit 3), Day 28 (Visit 4), and Day 56 (Visit 5). On Day 3, subject will be contacted by phone. Screening data will be reviewed to determine subject eligibility. Screening can occur on Day 1 prior to the start of study drug or within seven (7) days prior to Day 1. If Screening takes place prior to Day 1, then on Day 1, in order to reconfirm eligibility, an abbreviated physical exam, spirometry and a urine pregnancy test for females must be completed prior to dosing on Day 1. Subjects who meet all inclusion criteria and none of the exclusion criteria will be eligible for the study. Subjects will be permitted to remain in the clinical research center for the full five (5) days of continuous infusion at the discretion of the investigator. During each day of the infusion and for two subsequent days (Day 1 to Day 8), the subject will be instructed to consume at least two (2) liters of fluid. Calcium, BUN and creatinine may be checked more frequently at the discretion of the investigator. All subjects who had the study drug infusions started will be considered evaluable for safety and efficacy analyses. Incidence of AEs will be monitored during the trial. Total duration of subject participation will be up to 63 days. Additional data regarding long-term health impact may be ascertained through the CF Foundation National Patient Registry with optional patient consent. 5 CRITERIA FOR EVALUATION‌ 5.1 Primary Efficacy Endpoint‌ Difference between treatment groups in the proportion of subjects with a 5% or greater relative change in FEV1 (liters) from baseline to Day 28 5.2 Secondary Endpoints‌ • Difference between treatment groups in the change in sputum P. aeruginosa density based on quantitative cultures from baseline through end of follow-up • Difference between treatment groups in the emergence of other CF pathogens, incl...

Study Overview. The purpose of this study is to develop and assess a fitted condom sizing system, understand the current general condom use, identify new condom designs in which people have an interest, gather information about condom preferences, and provide an understanding of knowledge about abortion in Cape Town, South Africa.

Study Overview. The primary aim of this qualitative study is to identify the barriers and facilitators to self- efficacy for primary care providers as they address the healthcare needs of women survivors of sex trafficking. Furthermore, this study seeks to share findings and offer recommendations which may contribute to policy or program development to strengthen primary care response to sex trafficking. This study interviewed providers (N=11) who offer primary care services in 11 distinct care healthcare settings across seven U.S. states. Responses from semi-structured interviews were analyzed for common themes that indicate barriers and facilitators to self- efficacy for providers to identify and treat women survivors of sex trafficking. The providers engaged in this study currently address in practice the healthcare needs of adult women who are survivors of sex trafficking. Providers who are experienced in this area were interviewed because their experiences can provide insight that may be applicable to the broader population of primary care providers. To frame the language throughout this thesis, the term survivor refers to currently and formerly trafficked individuals; this term was selected to represent more empowering language when referring to those currently or formerly in trafficking and also is a more inclusive term given the patient mix primary care providers may encounter (▇▇▇▇▇▇▇▇, H., ▇▇▇▇▇▇▇▇▇, & ▇▇▇▇▇▇▇▇, J., 2017).

Study Overview. The purpose of this study is to conduct an evaluation of key components of the GHBS surveillance project. Additionally, this study proposes to determine what key components have contributed to the efficacy of the GHBS surveillance project.

Study Overview. Estimated time commitment: 1 to 2 hours or more either a bi-weekly or monthly cycle for a three year period • We generally estimate 1 hour of sampling time per site, per lake • This does not include travel time to or from the site, nor between sites on lakes with • Frequency of sampling for a Level 3 study varies from bi-weekly to monthly depending on the lake The primary Level 3 Study responsibilities volunteers are to: • Collect bi-weekly or monthly water samples and submit to an accredited laboratory for analysis • Record data on water clarity (using a Secchi disk), lake profile readings using a water meter, as well as general weather and site information • Maintain and store sampling equipment provided by the Ministry • Submit a photo or copy of the completed lab requisition form and field form to the Ministry following each sampling event • Volunteers also commit to entering the field data into the standardized digital format provided using online field data submission form or ministry provided standardized excel spreadsheet available here and sending to the Ministry monthly • Return sampling equipment to Ministry for maintenance and storage within 30 days of the final sampling event for the season, unless otherwise arranged Level 3 studies can be conducted on any lake of interest. Each volunteer group will be provided with coordinates to a predetermined station site from which to collect samples. Undertake at least 12 evenly spaced samples during ice-off season. When possible, samples should be taken between 10 am and 2 pm (best time to collect Secchi disk readings) and on the same day of the week. Do not sample on Thursday late, Friday, or Saturday as the lab is not available to receive samples within holding times. Provided by Ministry: • Secchi disk for measuring lake water clarity data and depth • Handheld thermometer • Field meter (such as a YSI) for lake profile data • Water sampling equipment and bottles • Forms, instructions, shipping labels, and shipping waybills Monitoring program may require watercrafts, fuel and other equipment required for safe watercraft operation, including personal flotation devices. These items must be supplied by volunteers.

Study Overview. Power Up for 30 (PU30) is a state-wide joint initiative through the Georgia Department of Public Health and Department of Education to encourage 30 minutes of physical activity each day among elementary school students. Some Georgia elementary schools have participated in PU30 and some have not. The purpose of this study is to identify and explore the barriers and facilitators to uptake and implementation of PU30 among Georgia elementary schools. Participation in this study includes a 30-45 minute in-person interview.

Study Overview. The current study uses a mixed methods, triangulation design (▇▇▇▇▇▇▇▇ & ▇▇▇▇▇, 2007; ▇▇▇▇▇▇▇▇ et al., 2011) that involves both secondary analysis of the Fragile Families and Child Wellbeing (FFCW) dataset and semi-structured qualitative interviews with recent TANF recipients to understand how TANF policies influence family violence and women’s wellbeing. A triangulation design allows us to give equal weight to quantitative and qualitative results, both of which are helpful in evaluating the application of the FSMV to the relationship between TANF and family violence. For Chapters 2 and 3, we apply a series of rigorous, quasi-experimental analyses of the FFCW dataset across waves 2, 3, 4, and 5 using Difference-in-Differences designs (Wing et al., 2018) to understand how exposure to TANF policy generosity affects FFCW participants’ risk of experiencing IPV, child maltreatment, economic pressure, and depression. We anticipate that AA families will benefit to a greater extent from more generous TANF policies compared to White families and so, for both Chapters 2 and 3, we also examine how AA race moderates the relationships between TANF policies and family violence using a modified Difference-in-Differences design using data from the same waves. For Chapter 4, we use semi-structured interviews (▇▇▇▇▇▇▇ et al., 2011; ▇▇▇▇▇▇, 2002) with women who have